AKT1 and neoplasm: KU-0060648 enhanced etoposide-induced tumour delay by up to 4.5-fold in SW620 and MCF7 xenografts, inhibited PI3K-AKT-mTOR signalling in hepatocarcinoma, and slowed MCF7 xenograft growth.